Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Oxaliplatin 197 Bevacizumab 162 Fluorouracil 155 Capecitabine 137 Gemcitabine 133 Leucovorin 112 pembrolizumab 99 Cisplatin 93 Drug Therapy 89 Irinotecan 81 Radiotherapy 73 sintilimab 70 durvalumab 65 130-nm albumin-bound paclitaxel 65 Paclitaxel 64 Specimen Handling 62 Cetuximab 61 lenvatinib 59 tislelizumab 58 Nivolumab 55 Magnetic Resonance Spectroscopy 55 Folfox protocol 55 Blood Specimen Collection 52 atezolizumab 48 Biopsy 46 Surgical Procedures, Operative 40 Taxes 38 Albumin-Bound Paclitaxel 38 Immune Checkpoint Inhibitors 37 HMPL-013 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Biguanides × Gastrointestinal × Clear all

NCT05663515 2026-06-02

EXCEED

AstraZeneca

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡